Demographics (2)
- age - Age at Entry (phv00190908.v1.p1)
- sex - Sex (phv00190909.v1.p1)
Disease Events (1)
- IS_TUMOR - Tumor status (phv00190921.v1.p1)
Race and Ethnicity (1)
- ncirace - NCI Race (phv00190917.v1.p1)
Other (29)
- AFFECTION_STATUS - Case control status of the subject (phv00190900.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00190920.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00190919.v1.p1)
- CONSENT - Consent group (phv00190897.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00190922.v1.p1)
- neutrotox - Toxicity due to Grade 4 Neutropenia (phv00190915.v1.p1)
- os_day - Overall survival time variable (phv00190913.v1.p1)
- pfs_cns - Progression-free survival censor variable (phv00190911.v1.p1)
- pfs_day - Progression-free survival time variable (phv00190912.v1.p1)
- Plate - Plate for genotypes (phv00190905.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00190923.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00190924.v1.p1)
- resp - Best confirmed response (phv00190910.v1.p1)
- SAMPLE_SOURCE - Source of sample (phv00190972.v1.p1)
- SAMPLE_USE - Sample Use (phv00190928.v1.p1)
- SAMPLEID - De-identified sample ID (phv00190918.v1.p1)
- SAMPLEID - ID for genotype data (phv00190902.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID from source (phv00190973.v1.p1)
- SOURCE_SUBJID - ID from source (phv00190899.v1.p1)
- SUBJ_SOURCE - Source of subject (phv00190898.v1.p1)
- SUBJID - De-identified subject ID (phv00190907.v1.p1)
- SUBJID - De-identified subject ID (phv00190901.v1.p1)
- SUBJID - De-identified subject ID (phv00190896.v1.p1)
- surv - Overall survival censor variable (phv00190914.v1.p1)
- totcyc - Total Number of treatment cycles (phv00190916.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00190926.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00190925.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00190927.v1.p1)
- Well - Well within plate (phv00190906.v1.p1)